SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,677,000 | +210.4% | 881,450 | -53.6% | 1.32% | +171.3% |
| Q2 2022 | $1,829,000 | -19.1% | 1,899,616 | 0.0% | 0.49% | -14.2% |
| Q1 2022 | $2,261,000 | -63.8% | 1,899,616 | -13.2% | 0.57% | -53.0% |
| Q4 2021 | $6,243,000 | -27.6% | 2,189,199 | 0.0% | 1.21% | -10.5% |
| Q3 2021 | $8,624,000 | -18.6% | 2,189,199 | 0.0% | 1.35% | +3.4% |
| Q2 2021 | $10,599,000 | -28.2% | 2,189,199 | 0.0% | 1.31% | -52.0% |
| Q1 2021 | $14,769,000 | -32.4% | 2,189,199 | 0.0% | 2.72% | +24.0% |
| Q4 2020 | $21,837,000 | +88.1% | 2,189,199 | +55.5% | 2.20% | -32.2% |
| Q3 2020 | $11,608,000 | -26.8% | 1,407,949 | -10.4% | 3.24% | -36.6% |
| Q2 2020 | $15,866,000 | +65.3% | 1,571,903 | -9.0% | 5.10% | -7.6% |
| Q1 2020 | $9,599,000 | -14.7% | 1,726,603 | 0.0% | 5.52% | +2.4% |
| Q4 2019 | $11,255,000 | -33.8% | 1,726,603 | 0.0% | 5.39% | -53.4% |
| Q3 2019 | $17,012,000 | +11.7% | 1,726,603 | 0.0% | 11.58% | +15.1% |
| Q2 2019 | $15,228,000 | +57.2% | 1,726,603 | +62.9% | 10.06% | +32.1% |
| Q1 2019 | $9,688,000 | +64.1% | 1,059,938 | 0.0% | 7.61% | +34.4% |
| Q4 2018 | $5,904,000 | – | 1,059,938 | – | 5.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |